Also known as: Luminist
Diagnostic platform for early detection of liver disease
Company was acquired
Event Year: 2015
Company was acquired
Event Year: 2015
Luminist Labs pioneered a novel, non-invasive diagnostic platform designed for the early identification and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Their technology aimed to provide a more accessible and patient-friendly approach to liver disease detection. In 2020, Luminist Labs was successfully acquired by DiscernDx, marking a significant milestone in the advancement of diagnostic solutions for liver health.
Luminist Labs pioneered a novel, non-invasive diagnostic platform designed for the early identification and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Their technology aimed to provide a more accessible and patient-friendly approach to liver disease detection. In 2020, Luminist Labs was successfully acquired by DiscernDx, marking a significant milestone in the advancement of diagnostic solutions for liver health.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2016
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2016
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 2
Hiring: No
Team size: 2
Hiring: No
